FDA Approves Brekiya, First and Only DHE Autoinjector, for Acute Treatment of Migraine, Cluster Headaches

Source: Pharmacy Times articles

The approved injection contains dihydroergotamine (DHE), which is the same medication used in hospitals, in a ready-to-use device.
Read More